Section Arrow
Quote
PRGO.NYSE
- Perrigo Company PLC
Quotes are at least 15-min delayed:2025/02/23 10:18 EST
Last
 25.34
+0.1 (+0.40%)
Day High 
25.57 
Prev. Close
25.24 
1-M High
25.66 
Volume 
1.88M 
Bid
23.25
Ask
26
Day Low
25.1115 
Open
25.24 
1-M Low
23.83 
Market Cap 
3.44B 
Currency USD 
P/E 2,758 
%Yield 4.36 
10-SMA 24.6 
20-SMA 24.76 
50-SMA 25.29 
52-W High 33.455 
52-W Low 23.14 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
-1.16/3.44
Enterprise Value
7.08B
Balance Sheet
Book Value Per Share
33.47
Cash Flow
Cash Flow Yield
0.07
Income Statement
Total Revenue
4.66B
Operating Revenue Per Share
34.11
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
UPCUniverse Pharmaceuticals Inc0.2003+0.0578+40.56%-- 
TLRYTilray Brands0.9452+0.0775+8.93%-- 
CGCCanopy Growth Corp1.615+0.005+0.31%-- 
TXMDTherapeuticsMD1.291+0.281+27.82%0.39PE
TEVATeva Pharmaceutical Industries Limited16.74-0.26-1.53%-- 
Quotes are at least 15-min delayed：2025/02/23 10:18 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.